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Abstract: 
 
Schizotypy provides a useful construct for understanding the development of schizophrenia 
spectrum disorders. As research on the epidemiology of psychotic symptoms and clinical risk for 
psychosis has expanded, conceptual challenges have emerged to comprehend the nature and 
borders of the space comprised between personality variation and psychosis. Schizotypy is 
considered in light of these more recent constructs. It is suggested that rather than being 
superseded by them due to their higher specificity and predictive power for transition to 
psychosis, schizotypy integrates them as it constitutes a dynamic continuum ranging from 
personality to psychosis. The advantages of schizotypy for studying schizophrenia etiology are 
discussed (eg, it facilitates a developmental approach and the identification of causal, resilience, 
and compensating factors and offers a multidimensional structure that captures etiological 
heterogeneity). An overview of putative genetic, biological, and psychosocial risk factors is 
presented, focusing on communalities and differences between schizotypy and schizophrenia 
spectrum disorders. The found notable overlap supports etiological continuity, and, 
simultaneously, differential findings appear that are critical to understanding resilience to 
schizophrenia. For example, discrepant findings in genetic studies might be interpreted as 
suggestive of sets of independent genetic factors playing a differential role in schizotypy and 
schizophrenia: some would influence variation specifically on schizotypy dimensions (ie, high vs 
low schizotypy, thereby increasing proneness to psychosis), some would confer unspecific 
liability to disease by impacting neural properties and susceptibility to environmental factors (ie, 
high vs low resilience to disorder) and some might contribute to disease–specific characteristics. 
Finally, schizotypy’s promise for studying gene-environment interactions is considered. 
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Schizotypy provides a useful construct for understanding 
the development of schizophrenia spectrum disorders. As 
research on the epidemiology of psychotic symptoms and 
clinical risk for psychosis has expanded, conceptual chal-
lenges have emerged to comprehend the nature and borders 
of the space comprised between personality variation and 
psychosis. Schizotypy is considered in light of these more 
recent constructs. It is suggested that rather than being 
superseded by them due to their higher specificity and pre-
dictive power for transition to psychosis, schizotypy inte-
grates them as it constitutes a dynamic continuum ranging 
from personality to psychosis. The advantages of schizotypy 
for studying schizophrenia etiology are discussed (eg, it 
facilitates a developmental approach and the identification 
of causal, resilience, and compensating factors and offers 
a multidimensional structure that captures etiological het-
erogeneity). An overview of putative genetic, biological, and 
psychosocial risk factors is presented, focusing on commu-
nalities and differences between schizotypy and schizophre-
nia spectrum disorders. The found notable overlap supports 
etiological continuity, and, simultaneously, differential find-
ings appear that are critical to understanding resilience to 
schizophrenia. For example, discrepant findings in genetic 
studies might be interpreted as suggestive of sets of indepen-
dent genetic factors playing a differential role in schizotypy 
and schizophrenia: some would influence variation specifi-
cally on schizotypy dimensions (ie, high vs low schizotypy, 
thereby increasing proneness to psychosis), some would con-
fer unspecific liability to disease by impacting neural prop-
erties and susceptibility to environmental factors (ie, high 
vs low resilience to disorder) and some might contribute to 
disease–specific characteristics. Finally, schizotypy’s prom-
ise for studying gene-environment interactions is considered.
Key words: psychotic-like experiences/psychosis/psychosis 
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Introduction
Schizotypy was introduced to represent the inherited vul-
nerability to schizophrenia spectrum disorders expressed 
as a multidimensional personality organization.1 The 
interaction of this vulnerability substrate with other 
genetic and environmental factors shapes the risk of 
presenting spectrum disorders and yields a wide range 
of phenotypic variance. Schizotypy is associated with 
heightened risk for the development of psychotic disor-
ders,2,3 although most schizotypes are not expected to 
develop psychosis, and constitutes a useful framework to 
study etiological factors of schizophrenia spectrum dis-
orders. Assessment of schizotypy provides an entry point 
for identifying individuals possessing liability to psycho-
sis prior to the appearance of clinical manifestations. This 
should facilitate the study of developmental pathways to 
psychosis and the identification of protective factors in 
individuals not presenting with typical confounding fac-
tors associated with schizophrenia spectrum disorders. 
The construct of schizotypy was developed both 
within the individual differences and medical traditions, 
which has led to differences in its conceptualization.4 The 
fully dimensional model of schizotypy, rooted in person-
ality tradition, proposes schizotypy as part of normal 
personality, being a source of both healthy variation and 
predisposition to psychosis. This model encompasses the 
more restrictive conceptualization derived from the medi-
cal tradition that dimensionality in psychosis exists but is 
restricted to the severity of presentation (from personality 
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pathology to the most extreme form of schizophre-
nia), viewing schizotypy as a forme fruste of  psychosis 
(quasi-dimensional model). These models involve differ-
ent views on the usefulness of schizotypy for studying 
schizophrenia spectrum disorders. The medical perspec-
tive tends to view schizotypy as a risk factor and a link 
in the chain towards schizophrenia. The reference point 
is the pathological, and the relevant focus is understand-
ing the transition from subclinical stages to psychosis. 
From this perspective, studying nonclinical variation is 
not highly informative,4 and this has hindered integration 
of knowledge derived from the individual differences and 
clinical fields. This has also slowed down the adoption 
of a developmental psychopathology perspective in the 
field of psychosis (which recognizes continuity between 
normal and abnormal and puts the emphasis in the 
study of interindividual differences and processes con-
trary to traditional disease models of causation),5 even 
if  a number of researchers pioneered a developmental 
conceptualization of schizophrenia in the early 90’s.6,7 In 
other psychopathology domains, more fruitful research 
has been conducted to understand connections between 
personality and psychopathology.8 This possibly relates 
to challenges posed by the larger phenotypic disconti-
nuity existing between trait and disorder in the case of 
psychosis compared with other domains, say trait anxiety 
and anxiety disorders, the failure of radical “Eysenckian 
dimensionalism” to recognize that there is a transition 
between healthy schizotypy personality and psychotic 
illness states (not meaning that they are unconnected), 
and that schizotypy presents more challenges than other 
personality dimensions (eg, definition of the low end of 
schizotypy).4
This article focuses on how schizotypy can be infor-
mative for studying schizophrenia spectrum disorders. 
It first addresses currently unresolved conceptual issues 
regarding schizotypy and then offers a brief  overview on 
candidate causal factors regarding commonalities and 
differences between schizotypy and schizophrenia spec-
trum disorders.
Conceptual Issues
Has the Usefulness of Schizotypy in Etiological 
Research Been Superseded by New Constructs?
As discussed in a previous article of this Special Issue,9 
there are numerous terms referring to the psychopatho-
logical space between psychological health and psycho-
sis. These terms variously refer to individual differences, 
subclinical manifestations, symptom–like experiences 
(eg, psychotic–like experiences [PLEs]), and clinical con-
ditions closer to psychosis but vary in terms of sever-
ity, frequency, and duration (eg, schizotypal personality 
disorder [SPD], prodromal or at-risk mental states, and 
attenuated psychotic symptoms syndrome). These con-
structs have often been proposed as alternatives to 
schizotypy, although some have been used interchange-
ably with schizotypy. PLEs10,11 are traditionally defined 
as mild versions of psychotic symptoms, but are also 
used interchangeably with schizotypy. We suggest that, 
in most cases, these alternatives are narrower construc-
tions interpretable as manifestations along the schizotypy 
continuum.
As epidemiological research on PLEs has expanded, 
there seem to be assumptions that PLEs are superior to 
schizotypy traits for assessing psychosis liability in non-
clinical populations. We suggest, however, that this may 
reflect a misinterpretation that schizotypy simply taps 
incipient risk for psychosis. Indeed, PLEs are useful 
predictors of psychosis development,12 because ostensi-
bly they are psychotic symptoms, albeit in milder form. 
Furthermore, we suggest that PLEs, like overt psychotic 
symptoms, can be thought of as manifestations of posi-
tive schizotypy. Simply put, PLEs are useful indicators of 
schizotypy and predictors of spectrum disorder and psy-
chosis risk in nondisordered schizotypes (although only 
representing one schizotypy dimension).
PLEs are also suggested to be more advantageous than 
schizotypy, because they are less unspecific. It should be 
noted, however, that both schizotypy traits and PLEs 
are present in samples of mood disorder patients,13 
predict mood disorders with psychotic features14, and 
share genetic factors with neuroticism.15 In fact, this is 
consistent with the idea of positive schizotypy convey-
ing expression of psychosis in both schizophrenia and 
mood psychoses. Rather than reflecting a lack of speci-
ficity, we believe schizotypy provides a useful mechanism 
for linking the experience of mood and non-mood psy-
choses. Furthermore, it highlights the importance of not 
establishing one-to-one associations between personality 
dimensions, subclinical states and specific disorders, as 
the early stages of psychopathology are not highly spe-
cific and interact dynamically with each other.16
An aspect seeming to have created confusion is the 
dual nature of schizotypy (as any other dimension) hav-
ing both state and trait manifestations. A useful analogy 
could be systemic disorders. Cardiovascular functioning, 
indexed partly by blood pressure, provides an analogy for 
schizotypy that is continuously distributed in the popula-
tion. This trait though has a dual nature, as it also shows 
fluctuations according to a number of exogenous and 
endogenous factors, thus presenting with properties of a 
state.4 Schizotypy tends to be used to refer to the stable 
personality structure, whereas PLEs are used to describe 
temporal states that fluctuate according to developmen-
tal transient states (eg, neurodevelopmental reorganiza-
tions) and are subject to environmental influences. So, on 
the one hand, we ascribe stability to schizotypy because 
we conceive of personality as a fixed temperamental 
set of stable propensities, but then it does not seem to 
be a good model to track the developmental pathways 
to clinical disorders because it is sensitive to endogenous 
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and exogenous variation. Most likely the problem is that 
true dynamic and developmental models of personality 
and psychopathology are not still well established, even if  
the notion of a sharp distinction between temperament, 
personality, and psychopathology and the assumption 
that personality is fixed and lacks a state component have 
been questioned.17
Another issue is whether clinical risk models are supe-
rior to schizotypy for studying schizophrenia etiology, 
given they have better psychosis-specificity and predictive 
power. As referred to in a previous article in this special 
issue,9 the interpretation that schizotypy is a poor model 
because it has low predictive value derives from a mis-
conception of schizotypy, as it is not expected that many 
individuals with high schizotypy will develop schizo-
phrenia spectrum disorders. Furthermore, help-seeking 
individuals meeting clinical risk criteria have more severe 
psychopathology than those with subclinical symptoms 
in the community (comorbidity bias), so transition rates 
to psychosis are naturally higher in the clinically defined 
population.16 Interestingly, Salokangas et  al18 found in 
ultra-high risk individuals that baseline self-reported 
schizotypy traits, specifically ideas of reference and lack 
of close interpersonal relationships, were associated with 
the risk of transition to psychosis. The co-ocurrence of 
these schizotypy features doubled the risk of transition at 
18 months, and this risk remained significant when con-
trolling for a diagnosis of SPD.
So What Is the “Added Value” of Schizotypy for the 
Study of Schizophrenia Etiology?
Schizotypy offers a number of advantages for concep-
tualizing the etiology, development, and expression of 
schizophrenia spectrum psychopathology. Firstly, it 
integrates a broad range of conditions including schizo-
phrenia and related disorders, spectrum personality 
disorders, the prodrome and at-risk mental states, sub-
clinical manifestations, and normal individual differ-
ences allowing for a dynamic developmental approach. 
This enables us to study a broad spectrum of variation, 
not just rare, and extreme manifestations like clinical 
disorders and the prodrome. This approach is consistent 
with NIMH Research Domain Criteria, which favor a 
bottom-up approach (from basic traits to higher order 
levels) of dimensional phenotypes.19 Also, this frame-
work allows the identification of factors contributing to 
movement along the schizotypy continuum at subclinical 
and clinical levels, taking into consideration that there 
might be different mechanisms operating within different 
ranges of severity along the continuum, including those 
that trigger the onset of clinical disorders. The study of 
subclinical expression should avoid many of the serious 
consequences of schizophrenia spectrum disorders that 
confound etiological research, thereby enhancing the 
study of psychological variables easily confounded by 
symptoms, severity, distress, comorbidity, and maladap-
tive strategies to emerging symptoms. Finally, schizotypy 
enhances the power of genetic and endophenotype stud-
ies that previously omitted subclinical cases or misclassi-
fied them as nonaffected.
In addition to integrating subclinical and clinical 
expressions, schizotypy also offers a multidimensional 
structure that captures the heterogeneity in the etiology, 
development, and expression of schizophrenia spectrum 
psychopathology. This heterogeneity and unique pat-
terns of impairment in patients are not well explained 
by unitary models of schizotypy and schizophrenia. For 
example, positive schizotypy is characterized by affec-
tive dysregulation and negative schemas whereas nega-
tive schizotypy is characterized by diminished positive 
affect and reward, showing similar social difficulties but 
driven by differential mechanisms.20,21 Furthermore, this 
multidimensional model should enhance understanding 
of the overlap and differentiation between affective and 
nonaffective psychosis—specifically, suggesting that both 
psychoses are high on positive schizotypy, but only non-
affective psychoses involve negative schizotypy.
Studying continuities and discontinuities between 
schizotypy and schizophrenia spectrum disorders should 
enhance understanding the heterogenetity in pathways 
to both clinical and nonclinical outcomes and help iden-
tify protective or compensating factors. The inclusion of 
nondisordered individuals who are putative risk carriers 
for schizophrenia spectrum disorders should enhance the 
search for resilience factors (the very concept of resilience 
relies on identification of individuals with risk factors 
who remain healthy). For example, it has been suggested 
that nondisordered schizotypy, SPD, and schizophrenia 
share left temporal volume reductions, suggesting com-
mon genetic vulnerability, whereas striatal and fron-
tal lobe abnormalities are not consistently seen in high 
schizotypy and SPD, suggesting that they may involve 
compensatory or protective factors.22 Schizotypal and 
schizophrenic individuals may share a common genetic 
vulnerability that renders the temporal cortex particu-
larly vulnerable to environmental insults. However, 
genetic or environmental factors that are different from 
those conferring susceptibility to schizophrenia, such as 
frontal lobe reserve or general intelligence, may decrease 
the impact of genetic susceptibility to schizophrenia and 
allow high schizotypy individuals to be more resistant to 
downstream effects of temporal dysfunction.22
A Brief Overview of Etiological Factors in Light of 
Continuities and Discontinuities Between Schizotypy 
and Schizophrenia Spectrum Disorders
In this section, we provide a brief  overview of candidate 
etiological factors for schizotypy and schizophrenia. If  
schizotypy is the personality matrix that increases the risk 
of developing schizophrenia spectrum disorders, at least 
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part of the factors explaining schizotypy variance should 
also be associated with schizophrenia. Simultaneously, as 
schizophrenia spectrum disorders are not the necessary 
outcome of schizotypy (health or nonpsychotic malad-
aptations can be associated with it), it is expected that 
there will be factors explaining schizotypy variance but 
not associated with schizophrenia. The focus of this over-
view will be to note the overlap and differences between 
schizotypy and schizophrenia spectrum disorders. 
Additional articles in this special issue deal with associa-
tions of schizotypy with candidate endophenotypes and 
risk mechanisms.23,24
Genetic Factors
The common genetic basis of schizotypy and schizo-
phrenia was believed to be a single dominant risk allele 
that, in interaction with environmental factors, leads to 
individual differences in schizotypy.1,25 Current opinion, 
however, is that about 8300 independent polymorphisms 
confer schizophrenia risk.26 These estimates have consid-
erable implications regarding the taxonicity vs dimen-
sionality debate, since a large number of contributing 
alleles supports the assumption of a continuous nature of 
schizotypy27—which, as mentioned earlier, does not pre-
clude the existence of a functional discontinuity between 
high schizotypy and schizophrenia.
As for concordance rates of schizophrenia spectrum 
diagnoses, values in schizotypy increase with higher 
genetic similarity to schizophrenics. A review28 indicated 
that relatives of patients primarily show elevated social-
interpersonal symptoms and small elevations in cogni-
tive perceptual and disorganized schizotypy. The reverse 
has also been shown,29–31 with offspring of highly schizo-
typic parents being at elevated risk for schizophrenia. 
A  large study32 examining the heritability of schizotypy 
concluded that on average 50% of schizotypy variance is 
explained by genetics. Hereof, social anhedonia appears 
to be most heavily genetically influenced.28,33,34
A variety of genes and polymorphisms identified as 
relevant for schizophrenia have been found to be associ-
ated with schizotypy. The most commonly examined single 
nucleotide polymorphism (SNP) in schizotypy is rs468035 
(COMT val158met), which influences dopaminergic neuro-
transmission and has overall been consistently associated 
with schizotypic traits (overview in36). When reviewing 
dimensions of schizotypy, however, rs4680 appears to be 
differentially related to them, mainly in dependence of the 
instrument used. Within the Wisconsin Schizotypy Scales, 
the val-allele appears more heavily related to increases in 
negative schizotypy,37 although others also find it coin-
ciding with higher perceptual aberration.38 Regarding the 
Schizotypal Personality Questionnaire (SPQ), the val-allele 
is associated with higher total scores,38,39 higher scores in 
both positive and negative factors39 or in all 3 facets (ie, 
positive, negative, and disorganized).40 A reverse effect was, 
however, published regarding the disorganized dimension 
of the SPQ-B41. Using the O-LIFE, the val-allele is only 
associated with positive but not negative or disorganized 
schizotypy.36 A  number of the cited studies indicate the 
possibility of molecular heterosis, namely lowest schizo-
typy scores in heterozygotes compared to both homozy-
gous groups. There is indication that rs4680 interacts with 
other relevant polymorphisms (eg, MAOA-uVNTR)36 and 
with age.42 Thus, rs4680 is indeed relevant for schizotypy, 
but further research in significantly larger samples is neces-
sary to identify exactly which features are age-specifically 
related to which allele; this question is currently being 
examined by us in an international sample comprised of 
most samples from the aforementioned individual articles.
Additionally, other dopamine-related genes show asso-
ciations with schizotypy, such as DRD243, SLC6A336,44, 
and MAOA.36 Furthermore, changes in expression pat-
terns of dopamine-relevant genes are often reported in 
schizophrenia,45,46 and a recent study shows that expres-
sion patterns of a number of these genes in human blood 
correlate with positive schizotypy.47
Other genes implicated in the etiology of schizophre-
nia have also been found to be associated with schizotypy, 
including NRG148, RGS449, PRODH,50 BDNF50, and 
ZNF804A.51,52 Individual studies suggest both an inter-
action between individual polymorphisms36 as well as 
additive effects.53 However, many of the aforementioned 
genes (with the exception of DRD2 and ZNF804A) no 
longer appear as significant hits in the latest schizophre-
nia Genome-Wide Association Study (GWAS).54 This 
underpins the usefulness of schizotypy as a research 
framework for schizophrenia: A critical issue of GWAS 
is the treatment of both cases and controls as homoge-
neous groups, as nondisordered schizotypes would be in 
the comparison group despite carrying the presumptive 
underlying vulnerability for schizophrenia. Additionally, 
all schizotypic variance within both groups is ignored. 
Furthermore, it must be considered that “negative studies 
should never be weighted as strongly as positive [ones]”55 
and “researchers need to look at the cumulative evidence 
for a gene’s involvement, be it genetic or biological.”55
Thus, polymorphisms not related to schizophrenia in 
GWAS, but consistently and plausibly linked to schizo-
typy, should not be easily dismissed. Grant56 has suggested 
that there are at least 2 groups of genetic factors. The first 
group mainly explains schizotypy variance and increases 
proneness for psychosis. The second group, which marks the 
risk of transition between high but healthy schizotypy and 
clinical schizophrenia, is probably independent of schizo-
typy, but conveys unspecific neuronal resilience. Thus, it is 
extremely likely in case-control designs that SNPs explain-
ing small schizotypic variance (both between and within 
groups) are lost due to the potentially far stronger effects 
of SNPs that explain the transition between healthy high 
schizotypy and schizophrenia. In other words, effects of 
SNPs that strongly but unspecifically influence whether a 
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person will be healthy or sick may overshadow the effects 
of SNPs that have specific but individually weak effects on 
schizotypic variance.
Further support for this hypothesis is given by the 
nature and function of the genes identified by GWAS.26 
There is currently no theoretical basis for many of the 
identified SNPs, most of them only reach genome-wide 
significance when samples from bipolar patients are 
included, most are involved in basal cellular metabolism, 
and many are well established as risk factors for unrelated 
somatic conditions. Recently, Ripke et al54 published new 
results, identifying 108 schizophrenia-associated loci 
(83 being new). Thus, further study of these 108 genetic 
markers is necessary regarding their role in schizotypy 
and their specificity to the psychosis continuum.
Two studies investigating the relation of  a polygenic 
risk score derived from GWAS26 indicate inverse asso-
ciations with PLEs57 and schizotypy (Hatzimanolis 
et al, in prep; Athens Study of  Psychosis Proneness and 
Incidence of  Schizophrenia [ASPIS]) in healthy partici-
pants; that is, high polygenic risk was associated with less 
PLEs and lower schizotypy scores. In both studies, single 
genes did not account for differences in schizotypy or 
psychotic experiences, but there was a trend for an asso-
ciation of  the gene ZNF804A in the direction previously 
reported for schizophrenia and schizotypy. Considering 
that the studies only included healthy participants, there 
might be an involuntary sampling bias in these studies, 
as those individuals with high polygenic risk scores and 
high schizotypic traits would be more likely to develop 
spectrum conditions than to be in a healthy sample, 
whereas those persons with high but healthy schizotypy 
should have a lower polygenic risk score. If  one assumes 2 
independent factors, namely schizotypy and health/resil-
ience, then it is plausible to propose that individuals with 
high schizotypy and low resilience would rarely be in the 
healthy population but, rather, develop schizophrenia. 
Thus, a polygenic risk score comprised of  many genetic 
variations involved in a number of  medical conditions 
(and therefore unlikely to be specific to schizotypy) should 
actually be inversely related to schizotypy in nonpatients. 
In sum, this would suggest that the association between 
genetic risk and schizotypy is not generally inverse com-
pared to schizophrenia, but rather differentially related, 
depending on the function of  individual genes; thus, 
lack of  genetic susceptibility for disease is protective for 
healthy schizotypes. Vice versa, genetically based low 
resilience may incur risk for a number of  medical con-
ditions, but only coincidentally high genetic schizotypy 
markers would lead to an incidence of  schizophrenia.
Biological Environmental Factors
As mentioned previously, heritability studies estimate that 
genetic factors explain about 50% of schizotypic variance. 
The remaining variance is explained by environmental 
factors that can be roughly divided into psychosocial and 
(neuro-) biological factors.
Supporting neurodevelopmental models, many biolog-
ical environmental factors are consistently shown to be 
involved in schizophrenia development; especially ante-
natal maternal viral infections, obstetric complications, 
elevated stress hormones, advanced parental age, and 
cannabis use.58,59 Some of these factors have also been 
investigated regarding schizotypy, most notably in large 
Finnish studies.60 A number of pre- and perinatal com-
plications have been associated with schizotypy. A large 
study61 found that individuals whose mothers had been 
exposed to influenza during the H3N2-epidemic in 1969 
while in the sixth gestational month presented with higher 
schizotypy as adults. Additionally, obstetric complica-
tions and low birth weight are associated with retrospec-
tive childhood schizotypal traits in adult schizophrenia 
spectrum patients62 and with schizotypy.63 Others60 found 
effects of lower birth and/or placental weight as well as 
head circumference, but only in women and limited to 
positive schizotypy traits. Associations of maternal dia-
betes and viral infections (especially in the first and sec-
ond trimester) with PLEs in adults are also reported,64 
but the numbers of affected individuals are minor in com-
parison to the numbers of individuals with identical com-
plications without PLEs. Finally, examination of other 
birth-related factors with regard to schizotypy65 showed 
no associations, although 60% of individuals within the 
high-schizotypy group reporting a schizophrenia spec-
trum diagnosis were born in winter.
Cannabis use has been extensively studied in cross-
sectional and longitudinal designs in healthy samples. 
Overall, findings indicate associations of schizotypy and 
PLEs with cannabis use66 and earlier age of initiation 
of use,67 although there are also contrary findings.68,69 
The association is found for the positive and disorga-
nized but not for the negative dimension.70 As for the 
temporal sequence, some longitudinal and age-stratified 
studies suggest inverse causality, namely that the devel-
opment of schizotypy influences the subsequent use of 
drugs.66,71,72 Also, studies controlling for effects of child-
hood schizotypy73,74 find that the effect of cannabis on 
PLEs is reduced when childhood schizotypy is included 
in the model. It should be noted, however, that both stud-
ies cannot fully exclude the possibility of early childhood 
“oddness” playing a role in the onset of cannabis use.
Finally, a number of studies examined links between 
indicators of early developmental insults and schizotypy. 
Hereof, neurological soft signs connected with schizo-
phrenia were found mainly to correlate with negative75,76 
but also with positive75,77 and disorganized schizotypy.77 
Also, dermatoglyphic anomalies have been associated 
with positive78 and negative schizotypy79 as well as SPD.80 
These findings add to the understanding that schizotypy 
also shares a common nongenetic biological contiuum 
with schizophrenia.
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Psychosocial Factors
Growing research on the effects of psychosocial adver-
sities on the brain is challenging the assumption that 
endophenotypic anomalies identified in schizotypy and 
schizophrenia only result from genetic and biological fac-
tors. For example, early life stress/maltreatment has been 
found to produce brain functional and structural altera-
tions,81 and there is evidence from animal models indi-
cating that certain environmental exposures can cause 
behavioral and brain phenotypes analogous to those 
observed in schizophrenia.82
A substantial body of work has shown that a range of 
social and interpersonal environmental factors are asso-
ciated with schizophrenia and schizotypy, with evidence 
appearing to be more robust for the positive dimension 
(reviews in).11,82–84 Although some findings are conflict-
ing and demonstration of a causal status is challeng-
ing,85 increasing agreement is emerging that psychosocial 
factors are not mere triggers of a genetic vulnerability 
but rather coparticipating factors in the psychosis con-
tinuum. Specifically, it has been suggested that epigenetic 
mechanisms might mediate environmental effects on gene 
function by ‘switching’ on and off  gene transcription 
throughout development, constituting a mechanism for 
rapid genome adaptations to the environment.86
In terms of macroenvironmental factors, there is 
strong evidence linking urbanicity during development 
with increased likelihood of both psychosis and PLEs, 
with dose-response relationship reported in a number 
of studies.87,88 The association of schizophrenia and 
poverty has been mixed, even if  poverty seems more 
strongly associated with psychosis than with other psy-
chiatric conditions.89 Furthermore, poverty showed a 
unique association with SPD dimensional scores in a 
general population survey examining all Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) personality disorders.90 An association has 
also been reported between socioeconomic disadvantage 
and risk for delusional–like experiences.91
Accumulating evidence indicates that minority position 
has an important role. Migrant status has been associated 
with increased risk for psychotic disorder as well as with 
greater prevalence of PLEs.11,92 The risk for psychotic 
disorder is increased in both first- and second-generation 
immigrants, suggesting that the post-migration context, 
rather than migration itself, may have a more prominent 
role.92 For example, the extent to which an individual 
at risk of experiencing exclusion/discrimination is an 
exception with regard to the greater social environment 
has been suggested as a mechanism underpinning the 
increased rates of psychotic phenomena in ethnic minor-
ity individuals.93 Thus, ethnic minority individuals living 
in areas with high levels of ethnic density appear to have 
a protective effect in relation to psychotic disorders and 
experiences.94,95
As for microenvironmental risk factors, a meta-anal-
ysis of 20 studies showed that parental communication 
deviance is associated with heightened risk for psycho-
sis96 and perceptions of parental behavior, particularly 
lower perceived care, are also related to psychotic disor-
ders and schizotypy traits.97 One of the most researched 
interpersonal factors is childhood adversity, with a recent 
meta-analysis indicating that trauma increases the risk of 
psychosis (including both clinical and subclinical expres-
sions) with an odds ratio of 2.7898. Childhood abuse, 
neglect, and bullying have all been linked to schizotypy, 
with some studies having controlled for relevant potential 
confounders (eg, family history of psychosis) and using 
prospective designs (reviews in).99,100 In general, the evi-
dence suggests that experiences involving an “intention to 
harm” element appear more strongly related to psychotic 
symptoms and experiences than adversities of a nonin-
tentional nature, like the death of a close person.101
Conclusions
Overall, schizotypy and schizophrenia seem to have a 
substantial overlap in terms of etiological factors at the 
genetic, biological, and psychosocial levels, which sup-
port the notion of not only phenomenological but also 
etiological continuity and the claim that schizotypy is a 
useful framework to investigate both normal individual 
differences and the etiology of schizophrenia spectrum 
disorders. Additionally, some differential findings were 
found, which are as relevant as similarities in order to 
define a complete account of the schizophrenia spectrum 
and to identify protective factors. The overview of recent 
genetic studies supported that there might be sets of 
independent factors playing a differential role in schizo-
typy and schizophrenia; some would influence variation 
specifically on schizotypy dimensions (ie, high vs low 
schizotypy), some would confer unspecific susceptibility 
to disease by impacting neural properties and suscepti-
bility to environmental insults (ie, high vs low resilience) 
and still some might contribute to disease-specific char-
acteristics. In addition, complex patterns of gene-gene, 
environment-environment, and gene-environment inter-
actions likely contribute to shape differential liability 
to clinical disorders, as suggested by the fact that the 
majority of individuals carrying genetic risk or exposed 
to environmental risk do not exhibit elevated rates of 
schizotypy or schizophrenia spectrum disorders. The 
study of differential effects of the same environmental 
factors in genetically diverse individuals (gene-environ-
ment-interaction) is challenging, but has already shown 
its potential to understand the development of spectrum 
disorders.102,103 Schizotypy provides a useful construct for 
studying gene-environment effects because it broadens 
the phenotype (and avoids misclassification of nondisor-
dered schizotypes as unaffected), allows for the examina-
tion of etiological factors without the confounds of the 
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consequences of schizophrenia, enhances identification 
of protective mechanisms by including the nondisordered 
members of the schizophrenia spectrum phenotype and, 
thus, promises to increase the power of such studies.
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